New drug combo may lengthen ovarian cancer survival
Wed, 15 Nov 2006 02:21 PM EST
... NEW YORK (Reuters Health) - "Major progress" has been achieved in developing chemotherapy combinations to prolong life in patients with ovarian cancer, according to a team of researchers in Greece, the UK, and the US. The top contender appears to be a combination of two types of cancer drugs -- platinums and taxanes -- administered intraperitoneally (directly into the abdominal cavity). ...

Not Signed In -


